Clinical Trial Update: Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating methods to control intestinal colonization with ESBL-producing Enterobacteriaceae in cancer patients has been termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Maria J.G.T. Vehreschild | Conditions: Cancer | Phase 2, Phase 3 | Status: TERMINATED